Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody
| dc.contributor.author | Singh, M. | |
| dc.contributor.author | Jackson, K.J.L. | |
| dc.contributor.author | Wang, J.J. | |
| dc.contributor.author | Schofield, P. | |
| dc.contributor.author | Field, M.A. | |
| dc.contributor.author | Koppstein, D. | |
| dc.contributor.author | Peters, T.J. | |
| dc.contributor.author | Burnett, D.L. | |
| dc.contributor.author | Rizzetto, S. | |
| dc.contributor.author | Nevoltris, D. | |
| dc.contributor.author | Masle-Farquhar, E. | |
| dc.contributor.author | Faulks, M.L. | |
| dc.contributor.author | Russell, A. | |
| dc.contributor.author | Gokal, D. | |
| dc.contributor.author | Hanioka, A. | |
| dc.contributor.author | Horikawa, K. | |
| dc.contributor.author | Colella, A.D. | |
| dc.contributor.author | Chataway, T.K. | |
| dc.contributor.author | Blackburn, J. | |
| dc.contributor.author | Mercer, T.R. | |
| dc.contributor.author | et al. | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Pathogenic autoantibodies arise in many autoimmune diseases, but it is not understood how the cells making them evade immune checkpoints. Here, single-cell multi-omics analysis demonstrates a shared mechanism with lymphoid malignancy in the formation of public rheumatoid factor autoantibodies responsible for mixed cryoglobulinemic vasculitis. By combining single-cell DNA and RNA sequencing with serum antibody peptide sequencing and antibody synthesis, rare circulating B lymphocytes making pathogenic autoantibodies were found to comprise clonal trees accumulating mutations. Lymphoma driver mutations in genes regulating B cell proliferation and V(D)J mutation (CARD11, TNFAIP3, CCND3, ID3, BTG2, and KLHL6) were present in rogue B cells producing the pathogenic autoantibody. Antibody V(D)J mutations conferred pathogenicity by causing the antigen-bound autoantibodies to undergo phase transition to insoluble aggregates at lower temperatures. These results reveal a pre-neoplastic stage in human lymphomagenesis and a cascade of somatic mutations leading to an iconic pathogenic autoantibody. | |
| dc.description.statementofresponsibility | Mandeep Singh, Katherine J.L. Jackson, Jing J. Wang, Peter Schofield, Matt A. Field ... Maureen Rischmueller ... et al. | |
| dc.identifier.citation | Cell, 2020; 180(5):878-894 | |
| dc.identifier.doi | 10.1016/j.cell.2020.01.029 | |
| dc.identifier.issn | 0092-8674 | |
| dc.identifier.issn | 1097-4172 | |
| dc.identifier.orcid | Rischmueller, M. [0000-0001-5057-3286] | |
| dc.identifier.uri | http://hdl.handle.net/2440/124829 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.rights | © 2020 Elsevier Inc. | |
| dc.source.uri | https://doi.org/10.1016/j.cell.2020.01.029 | |
| dc.subject | autoantibody | |
| dc.subject | cryoglobulinemia | |
| dc.subject | lymphoma | |
| dc.subject | rheumatoid factor | |
| dc.subject | single cell omics | |
| dc.subject | somatic mutation | |
| dc.subject | vasculitis | |
| dc.title | Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody | |
| dc.type | Journal article | |
| pubs.publication-status | Published |